Circular PVT1 regulates cell proliferation and invasion via miR-149-5p/FOXM1 axis in ovarian cancer

被引:27
作者
Li, Min [1 ]
Chi, Chi [1 ]
Zhou, Liqin [2 ]
Chen, Youguo [1 ]
Tang, Xiuwu [1 ]
机构
[1] Soochow Univ, Affiliated Hosp 1, Dept Gynecol & Obstet, Suzhou 215006, Jiangsu, Peoples R China
[2] Suzhou Xiangcheng Peoples Hosp, Dept Gynecol & Obstet, Suzhou 215006, Jiangsu, Peoples R China
来源
JOURNAL OF CANCER | 2021年 / 12卷 / 02期
关键词
PVT1; ovarian cancer; bioinformatics; circRNA; FOXM1; NONCODING RNA PVT1; LUNG-CANCER; LNCRNA PVT1; EXPRESSION; APOPTOSIS; PROGNOSIS; FOXM1;
D O I
10.7150/jca.52234
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Long non-coding RNA plasmacytoma variant translocation 1 (PVT1) is a dysregulated gene in malignancy and is associated with oncogenesis. In this study, we found PVT1 RNA was an ovarian specific expressing gene, and overexpressed in multiple cancer types, including ovarian cancer (OV). Higher expression levels of PVT1 are related to shorter survival time in OV patients, especially in patients with advanced stage and grade. Recent studies indicated circular PVT1 also had an important role in cancer progression, whose roles in OV remain unclear. Knockdown of circular PVT1 significantly suppressed OV cell proliferation, migration and invasion. Bioinformatics analysis demonstrated that circular PVT1 was involved in regulating angiogenesis, osteoblast differentiation, regulation of cell growth, type B pancreatic cell proliferation, negative regulation of apoptotic process, phospholipid homeostasis, regulation of neurogenesis, definitive hemopoiesis, cell migration, regulation of glucose metabolic process, central nervous system development and type 2 immune response. Our data showed miR-149-5p targeted FOXM1, which was regulated by circular PVT1. Forkhead Box M1 (FOXM1) expression in ovarian cancer exhibited high level when compared with normal tissues, and had relation with relatively poor survival. FOXM1 promoted cell viability and reduced FOXM1 could rescue circular influence of circular PVT1-caused carcinoma induction. In conclusion, circular PVT1 increased FOXM1 level via binding to miR-149-5p and thus affected ovarian cancer cell viability and migration.
引用
收藏
页码:611 / 621
页数:11
相关论文
共 55 条
[1]   Circular PVT1: an oncogenic non-coding RNA with emerging clinical importance [J].
Adhikary, Jayashree ;
Chakraborty, Sourabrata ;
Dalal, Subhamita ;
Basu, Souradip ;
Dey, Abhijit ;
Ghosh, Amlan .
JOURNAL OF CLINICAL PATHOLOGY, 2019, 72 (08) :513-519
[2]  
[Anonymous], 2019, J SOFTWARE
[3]   Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1 [J].
Boyerinas, Benjamin ;
Park, Sun-Mi ;
Murmann, Andrea E. ;
Gwin, Katja ;
Montag, Anton G. ;
Zillhardt, Marion ;
Hua, You-Jia ;
Lengyel, Ernst ;
Peter, Marcus E. .
INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (08) :1787-1797
[4]   The Genotype-Tissue Expression (GTEx) Project [J].
Carithers, Latarsha J. ;
Moore, Helen M. .
BIOPRESERVATION AND BIOBANKING, 2015, 13 (05) :307-308
[5]   LncRNA PVT1 promotes proliferation and invasion through enhancing Smad3 expression by sponging miR-140-5p in cervical cancer [J].
Chang, Qing-Qing ;
Chen, Chun-Yan ;
Chen, Zhao ;
Chang, Shuai .
RADIOLOGY AND ONCOLOGY, 2019, 53 (04) :443-452
[6]   Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer [J].
Chen, Jie ;
Li, Yan ;
Zheng, Qiupeng ;
Bao, Chunyang ;
He, Jian ;
Chen, Bin ;
Lyu, Dongbin ;
Zheng, Biqiang ;
Xu, Yu ;
Long, Ziwen ;
Zhou, Ye ;
Zhu, Huiyan ;
Wang, Yanong ;
He, Xianghuo ;
Shi, Yingqiang ;
Huang, Shenglin .
CANCER LETTERS, 2017, 388 :208-219
[7]   LncRNA PVT1 promotes ovarian cancer progression by silencing miR-214 [J].
Chen, Ying ;
Du, Hui ;
Bao, Lewen ;
Liu, Wenxin .
CANCER BIOLOGY & MEDICINE, 2018, 15 (03) :238-250
[8]   Long non-coding RNA PVT1 as a novel biomarker for diagnosis and prognosis of non-small cell lung cancer [J].
Cui, Di ;
Yu, Cai-Hua ;
Liu, Min ;
Xia, Qing-Qing ;
Zhang, Yu-Feng ;
Jiang, Wei-Long .
TUMOR BIOLOGY, 2016, 37 (03) :4127-4134
[9]   miRNAs and ovarian cancer: An overview [J].
Deb, Bornali ;
Uddin, Arif ;
Chakraborty, Supriyo .
JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (05) :3846-3854
[10]   Imaging and therapy of ovarian cancer: clinical application of nanoparticles and future perspectives [J].
Di Lorenzo, Giovanni ;
Ricci, Giuseppe ;
Severini, Giovanni Maria ;
Romano, Federico ;
Biffi, Stefania .
THERANOSTICS, 2018, 8 (16) :4279-4294